Insider Buying: Anteris Technologies Global (NASDAQ:AVR) Major Shareholder Buys $4,869,897.05 in Stock

Anteris Technologies Global Corp. (NASDAQ:AVR) major shareholder L1 Capital Pty Ltd purchased 648,455 shares of the firm’s stock in a transaction on Monday, October 5th. The shares were acquired at an average cost of $7.51 per share, with a total value of $4,869,897.05. Following the completion of the acquisition, the insider directly owned 12,778,380 shares in the company, valued at $95,965,633.80. The trade was a 5.35% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Large shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

L1 Capital Pty Ltd also recently made the following trade(s):

• On Tuesday, October 6th, L1 Capital Pty Ltd acquired 272,695 shares of Anteris Technologies Global stock. The stock was acquired at an average price of $7.18 per share, for a total transaction of $1,957,950.10.
• On Friday, October 2nd, L1 Capital Pty Ltd acquired 236,354 shares of Anteris Technologies Global stock. The stock was acquired at an average price of $7.78 per share, for a total transaction of $1,838,834.12.
• On Thursday, October 1st, L1 Capital Pty Ltd bought 322,940 shares of Anteris Technologies Global stock. The shares were acquired at an average cost of $7.60 per share, for a total transaction of $2,454,344.00.
• On Wednesday, September 30th, L1 Capital Pty Ltd bought 74,286 shares of Anteris Technologies Global stock. The shares were acquired at an average price of $7.72 per share, with a total value of $573,487.92.
• On Friday, August 28th, L1 Capital Pty Ltd sold 7,800 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.83, for a total value of $68,874.00.
• On Tuesday, August 11th, L1 Capital Pty Ltd sold 375,815 shares of Anteris Technologies Global stock. The shares were sold at an average price of $9.30, for a total transaction of $3,495,079.50.
• On Monday, August 10th, L1 Capital Pty Ltd sold 251,844 shares of Anteris Technologies Global stock. The shares were sold at an average price of $9.10, for a total transaction of $2,291,780.40.
• On Thursday, August 6th, L1 Capital Pty Ltd sold 174,721 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.10, for a total transaction of $1,415,240.10.
• On Tuesday, August 4th, L1 Capital Pty Ltd sold 480,608 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.30, for a total transaction of $3,989,046.40.
• On Wednesday, August 5th, L1 Capital Pty Ltd sold 14,581 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.23, for a total transaction of $120,001.63.

Anteris Technologies Global Price Performance

NASDAQ AVR opened at $6.63 on Friday. The firm’s fifty day moving average price is $8.41 and its 200 day moving average price is $8.03. The company has a market capitalization of $646.16 million, a price-to-earnings ratio of -3.40 and a beta of 1.87. Anteris Technologies Global Corp. has a 12 month low of $3.30 and a 12 month high of $11.06.

Anteris Technologies Global (NASDAQ:AVR) last announced its quarterly earnings results on Tuesday, August 11th. The company reported ($0.30) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.09). Anteris Technologies Global had a negative return on equity of 77.69% and a negative net margin of 4,619.27%.The company had revenue of $1.01 million for the quarter, compared to analyst estimates of $1.50 million. During the same quarter in the prior year, the business earned ($0.58) earnings per share. As a group, sell-side analysts forecast that Anteris Technologies Global Corp. will post -1.21 earnings per share for the current year.

Institutional Investors Weigh In On Anteris Technologies Global

Several hedge funds have recently made changes to their positions in the business. Farther Finance Advisors LLC lifted its position in Anteris Technologies Global by 26,789.3% during the 3rd quarter. Farther Finance Advisors LLC now owns 15,058 shares of the company’s stock worth $117,000 after acquiring an additional 15,002 shares during the period. Nantahala Capital Management LLC purchased a new position in shares of Anteris Technologies Global in the 2nd quarter valued at approximately $33,325,850. One68 Global Capital LLC acquired a new position in shares of Anteris Technologies Global in the second quarter valued at approximately $128,000. Bank of America Corp DE acquired a new position in shares of Anteris Technologies Global in the second quarter valued at approximately $1,907,000. Finally, AWM Investment Company Inc. purchased a new stake in shares of Anteris Technologies Global during the second quarter worth approximately $1,133,000.

Key Stories Impacting Anteris Technologies Global

Here are the key news stories impacting Anteris Technologies Global this week:

• Positive Sentiment: Major shareholder continued buying. L1 Capital purchased 272,695 AVR shares for approximately $1.96 million at an average price of $7.18, increasing its position by 4.48%. This follows several additional purchases in late September and early October, signaling continued confidence from a significant investor. SEC filing on L1 Capital’s AVR purchase
• Neutral Sentiment: Barclays initiated coverage with a Hold-equivalent view. Barclays’ reported “Hold” or “Equal Weight” stance suggests the firm sees limited near-term evidence for a stronger bullish recommendation. The coverage provides additional visibility but is unlikely to be a major catalyst by itself. Barclays AVR rating report
• Neutral Sentiment: Share and incentive-plan records were updated. Anteris reported changes involving CHESS Depositary Interests and employee equity incentives. These administrative updates do not provide a new clinical or commercial catalyst, though investors will monitor their effect on the share count. Anteris CDI and equity incentive update
• Negative Sentiment: Expanded unquoted equity may raise dilution concerns. The employee incentive-plan announcement adds to investor attention on potential future share issuance. For a clinical-stage company that is not yet profitable, the prospect of additional equity compensation or dilution can weigh on sentiment. Anteris employee incentive-plan announcement

Analyst Ratings Changes

AVR has been the subject of a number of research analyst reports. Cantor Fitzgerald reissued an “overweight” rating and issued a $15.00 target price on shares of Anteris Technologies Global in a research report on Friday, August 14th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Anteris Technologies Global in a research report on Wednesday, August 26th. Finally, Barclays raised Anteris Technologies Global to a “hold” rating in a report on Wednesday. Three analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $14.00.

About Anteris Technologies Global

Anteris Technologies Global is a clinical-stage structural heart company developing technologies intended to treat aortic valve disease. The company’s lead product is the DurAVR transcatheter heart valve, which is designed to replicate the performance characteristics of a healthy human aortic valve and restore more natural blood flow.

Anteris uses its proprietary ADAPT tissue-engineering technology to create heart-valve materials designed for durability and biocompatibility. The company is focused primarily on transcatheter aortic valve replacement and related structural-heart applications, with its products progressing through clinical development and regulatory evaluation rather than broad commercial distribution.

The company has Australian origins and maintains operations and clinical-development activities in both Australia and the United States.